HoneyLab undertake extensive Research & Development to develop novel and effective natural products. For some products, such as Melzest, Melzing and Melrest, this involves developing novel formulations of natural products for which strong science already exists. For others, such as Honevo, clinical studies are undertaken. In general, the clinical trials process is as follows:
Phase 1 studies – these “first time use by humans” studies are rarely required as most natural products have data to show that they are not dangerous.
Phase 2 studies – on most occasions, the first study is a phase 2 study – this is a smallish study of around 10-50 participants that is unlikely to prove that the product is safe and effective, but will give a signal as to whether the product may be effective and therefore if it is sensible to invest in a phase 3 study. Learnings from the phase 2 study also improve the quality of the phase 3 study, and the results of the phase 2 study are used to power the phase 3 study i.e. determine how many subjects are needed.
Phase 3 studies – these are large studies that provide definitive proof as to whether a product is safe and effective. 100-1,000 participants are usually needed, with the exact number being derived from the phase 2 study.
HoneyLab has undertaken the world’s largest programme of clinical research into the benefits of medical-grade honey for skin diseases, proving that our patented formulation Honevo is an effective treatment for several conditions. Clinical studies of kanuka oil products for skin diseases are ongoing and we have a large pipeline of other products at various stages of development.
Many of HoneyLab’s research studies have been published in prestigious medical journals including the British Medical Journal Open and the European Journal of Nutrition. Below is a list of our published research.
HoneyLab are conducting the world’s largest research programme into the medical uses of honey. We have a large pipeline of new products to test, with many trials planned and a number of trials ongoing. Below is a list of our published research.
Holt S et al. A single-blind randomised controlled trial of a topical kanuka honey formulation for the treatment of acne – oral presentation. New Zealand Dermatological Society Annual Meeting, 26th-29th August 2015, Auckland, New Zealand
Holt S et al. A topical kanuka honey formulation is an effective treatment for rosacea – oral presentation. New Zealand Dermatological Society Annual Meeting, 26th-29th August 2015, Auckland, New Zealand
Dear HoneyLab Customers, please note we are still experiencing long shipping delays to destinations outside of New Zealand due to COVID-19, so we would appreciate your continued patience. Thank you for your ongoing support.Dismiss